EIT Health invites organisations from industry, education and research to submit proposals for the development of a new EIT Label-certified Biotech pathway within the Certified Innovation Path (CIP) portfolio, complementing the existing Health Data, Digital Medical Devices and High Value Care pathways.
Funded projects will design and deliver personalised learning courses for graduates and professionals across the health biotechnology value chain. The pathway will equip participants with the innovation, entrepreneurship and biotech expertise needed to translate scientific advances into scalable, market-ready healthcare solutions across Europe.
EIT Health will co-fund collaborative consortium projects to design and deliver a new Certified Innovation Path (CIP) in Biotechnology, complementing the existing Health Data, Digital Medical Devices and High Value Care pathways.
This EIT Label aligned, personalised learning pathway will target graduates and professionals seeking to upskill across the health biotechnology value chain.
The Biotech Certified Innovation Path must:
Proposed courses must aim to:
The maximum EIT Health grant that is available for development of the CIP in Biotechnology is €240.000.
The budget should be structured around two components, course development and course updates.
The following costs will not be eligible as EIT Health assumes responsibility for such costs:
EIT Health will fund a maximum of 50% of the project’s total costs, up to the maximum EIT Health funding described above. The consortium must secure the remaining 50% co-funding from other sources (non-EIT Health)
Projects must not run longer than 15 months, with an effective start date on 01 January 2027.
After the first 9 months, the CIP pathway should be available online for registrations and programme participation.
In accordance with the Horizon Europe Work Programme, to be eligible for funding, the applicant must be established in one of the eligible countries, i.e.:
Legal entities, which are established in countries not listed above will be eligible for funding if their participation is considered essential for implementing the action by the EIT.
Consortium composition
Active and substantive involvement of non-academic or industry partners is essential, as a highly integrated, innovative learning by doing approach is a core principle of EIT Labelled Fellowships. Learners are expected to work both individually and in interdisciplinary teams, typically addressing authentic challenges articulated by industry and other non-academic partners.